Patanjali's Rs 4,500 Crore Insurance Deal Gets IRDAI Nod: Here's What It Means

Published 30 July 2026 · finance

Patanjali's Rs 4,500 Crore Insurance Deal Gets IRDAI Nod: Here's What It Means Published By, Last Updated: July 30, 2026, 18:54 IST IRDAI has approved

Patanjali's Rs 4,500 Crore Insurance Deal Gets IRDAI Nod: Here's What It Means Published By, Last Updated: July 30, 2026, 18:54 IST IRDAI has approved the proposed acquisition of Magma General Insurance shares by a Patanjali-led consortium, allowing the buyer group to move ahead with ownership transfer process. Baba Ramdev IRDAI has approved Patanjali Ayurved-led consortium’s proposed acquisition of Magma General Insurance, paving the way for the completion of the nearly Rs 4,500-crore deal. The approved buyer group comprises Patanjali Ayurved Ltd along with S.R. Foundation, RITI Foundation, RR Foundation, Suruchi Foundation and Swati Foundation. The consortium plans to purchase shares from the insurer’s existing shareholders. What IRDAI’s Approval Means?

With the insurance regulator’s clearance now in place, the consortium can proceed with the share acquisition, subject to the conditions laid down by IRDAI. The approval is valid for three months from July 28, 2026, during which the transaction must be completed. Approval Under Insurance Laws IRDAI cleared the transaction under Section 6A of the Insurance Act, 1938, along with the IRDAI (Registration, Capital Structure, Transfer of Shares and Amalgamation of Insurers) Regulations, 2024. The ownership transfer will take effect only after all contractual, regulatory and closing formalities are completed. Why Is This Deal Important? The approval marks Patanjali Ayurved’s entry into India’s insurance sector, significantly expanding the Baba Ramdev-led group’s presence beyond FMCG, healthcare and wellness products.

It also removes the biggest regulatory hurdle in the nearly Rs 4,500-crore acquisition, bringing the change in ownership of Magma General Insurance closer to completion. Deal In The Work Since 2025 The acquisition was first announced in March 2025 after a Share Purchase Agreement (SPA) was signed between the Patanjali-led consortium and the existing shareholders. Since the deal required regulatory approvals, the long-stop date under the SPA was extended in March 2026. With IRDAI’s clearance now secured, the transaction has crossed a major milestone and is closer to being completed. News18 Newsletter Handpicked stories, in your inbox A newsletter with the best of our journalism submit About the Author Anushka Vats Anushka Vats is a Sub-Editor at News18.com with a passion for storytelling and a curiosity that extends beyond the newsroom.